Replicated association between genetic variation in the PARK2 gene and blood pressure

Clinica Chimica Acta

Volumn 412, Issue 17-18, 2011, Pages 1673-1677

  Jin, Hyun Seok ^a   Hong, Kyung Won ^b,c   Kim, Bo Young ^a   Kim, Jeonghyun ^a   Yoo, Young Hyun ^d   Oh, Bermseok ^c   Jeong, Seon Yong ^a  

^a Ajou University School of Medicine   (South Korea)

^b Korea National Institute of Health   (South Korea)

^c Kyung Hee University Hospital   (South Korea)

^d Dong A University   (South Korea)

Author keywords

Association; Blood pressure; Mitochondrial fusion fission; Mitophagy; PARK2; Single nucleotide polymorphism

Indexed keywords

PARKIN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE PREDISPOSITION; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MITOCHONDRION; PARK2 GENE; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTOLIC BLOOD PRESSURE;

ADULT; BLOOD PRESSURE; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; GENETIC VARIATION; HUMANS; MALE; MIDDLE AGED; NIGERIA; POLYMORPHISM, SINGLE NUCLEOTIDE; REPUBLIC OF KOREA; UBIQUITIN-PROTEIN LIGASES;

EID: 79959324624     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2011.05.026     Document Type: Article

References (37)

1. Binder A. A review of the genetics of essential hypertension. Curr Opin Cardiol 2007, 22:176-184.
2. Doris P.A. The genetics of blood pressure and hypertension: the role of rare variation. Cardiovasc Ther 2011, 29:37-45.
3. Lifton R.P., Gharavi A.G., Geller D.S. Molecular mechanisms of human hypertension. Cell 2001, 104:545-556.
4. Hunt S.C. Genetic architecture of complex traits predisposing to nephropathy: hypertension. Semin Nephrol 2010, 30:150-163.
5. Ehret G.B. Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr Hypertens Rep 2010, 12:17-25.
6. Adeyemo A., Gerry N., Chen G., et al. A genome-wide association study of hypertension and blood pressure in African Americans. PLoS Genet 2009, 5:e1000564.
7. Rafiq S., Anand S., Roberts R. Genome-wide association studies of hypertension: have they been fruitful?. J Cardiovasc Transl Res 2010, 3:189-196.
8. Zhu X., Luke A., Cooper R.S., et al. Admixture mapping for hypertension loci with genome-scan markers. Nat Genet 2005, 37:177-181.
9. Krushkal J., Ferrell R., Mockrin S.C., Turner S.T., Sing C.F., Boerwinkle E. Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation 1999, 99:1407-1410.
10. Tayo B.O., Luke A., Zhu X., Adeyemo A., Cooper R.S. Association of regions on chromosomes 6 and 7 with blood pressure in Nigerian families. Circ Cardiovasc Genet 2009, 2:38-45.
11. Zhang Y., Gao J., Chung K.K., Huang H., Dawson V.L., Dawson T.M. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A 2000, 97:13354-13359.
12. Kitada T., Asakawa S., Hattori N., et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 1998, 392:605-608.
13. Narendra D.P., Youle R.J. Targeting Mitochondrial Dysfunction: Role for PINK1 and Parkin in Mitochondrial Quality Control. Antioxid Redox Signal 2011, 14:1929-1938.
14. Whitworth A.J., Pallanck L.J. The PINK1/Parkin pathway: a mitochondrial quality control system?. J Bioenerg Biomembr 2009, 41:499-503.
15. Twig G., Hyde B., Shirihai O.S. Mitochondrial fusion, fission and autophagy as a quality control axis: the bioenergetic view. Biochim Biophys Acta 2008, 1777:1092-1097.
16. Park J., Lee G., Chung J. The PINK1-Parkin pathway is involved in the regulation of mitochondrial remodeling process. Biochem Biophys Res Commun 2009, 378:518-523.
17. Ramachandran A., Levonen A.L., Brookes P.S., et al. Mitochondria, nitric oxide, and cardiovascular dysfunction. Free Radic Biol Med 2002, 33:1465-1474.
18. Zimmerman M.C., Zucker I.H. Mitochondrial dysfunction and mitochondrial-produced reactive oxygen species: new targets for neurogenic hypertension?. Hypertension 2009, 53:112-114.
19. Puddu P., Puddu G.M., Cravero E., De Pascalis S., Muscari A. The putative role of mitochondrial dysfunction in hypertension. Clin Exp Hypertens 2007, 29:427-434.
20. Lassegue B., Griendling K.K. Reactive oxygen species in hypertension; an update. Am J Hypertens 2004, 17:852-860.
21. Dedkova E.N., Blatter L.A. Mitochondrial Ca2+ and the heart. Cell Calcium 2008, 44:77-91.
22. Palacino J.J., Sagi D., Goldberg M.S., et al. Mitochondrial dysfunction and oxidative damage in Parkin-deficient mice. J Biol Chem 2004, 279:18614-18622.
23. Dodson M.W., Guo M. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease. Curr Opin Neurobiol 2007, 17:331-337.
24. Cho Y.S., Go M.J., Kim Y.J., et al. A large-scale genome-wide association study of Asian populations uncovers genetic factors influencing eight quantitative traits. Nat Genet 2009, 41:527-534.
25. Hong K.W., Lim J.E., Oh B. A regulatory SNP in AKAP13 is associated with blood pressure in Koreans. J Hum Genet 2011, 56:205-210.
26. Gottlieb R.A., Gustafsson A.B. Mitochondrial turnover in the heart. Biochim Biophys Acta 2011, 1813:1295-1301.
27. Ziviani E., Tao R.N., Whitworth A.J. Drosophila parkin requires PINK1 for mitochondrial translocation and ubiquitinates mitofusin. Proc Natl Acad Sci U S A 2010, 107:5018-5023.
28. Gegg M.E., Schapira A.H. PINK1-parkin-dependent mitophagy involves ubiquitination of mitofusins 1 and 2: implications for Parkinson disease pathogenesis. Autophagy 2011, 7:243-245.
29. Vives-Bauza C., Zhou C., Huang Y., et al. PINK1-dependent recruitment of Parkin to mitochondria in mitophagy. Proc Natl Acad Sci U S A 2010, 107:378-383.
30. Lutz A.K., Exner N., Fett M.E., et al. Loss of parkin or PINK1 function increases Drp1-dependent mitochondrial fragmentation. J Biol Chem 2009, 284:22938-22951.
31. Deng H., Dodson M.W., Huang H., Guo M. The Parkinson's disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc Natl Acad Sci U S A 2008, 105:14503-14508.
32. Grunewald A., Voges L., Rakovic A., et al. Mutant Parkin impairs mitochondrial function and morphology in human fibroblasts. PLoS One 2010, 5:e12962.
33. Ong S.B., Hausenloy D.J. Mitochondrial morphology and cardiovascular disease. Cardiovasc Res 2010, 88:16-29.
34. Kane L.A., Youle R.J. Mitochondrial fission and fusion and their roles in the heart. J Mol Med 2010, 88:971-979.
35. Yan L., Sadoshima J., Vatner D.E., Vatner S.F. Autophagy in ischemic preconditioning and hibernating myocardium. Autophagy 2009, 5:709-712.
36. Hamacher-Brady A., Brady N.R., Gottlieb R.A. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J Biol Chem 2006, 281:29776-29787.
37. Wang Z.V., Rothermel B.A., Hill J.A. Autophagy in hypertensive heart disease. J Biol Chem 2010, 285:8509-8514.